Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ENVB | Enveric Biosciences | $3.65 | $1.83 | 100.55% | 158.7M | $3.4M | $1.71$17.84 |
| FGI | Fgi Industries | $9.79 | $3.29 | 50.62% | 2.5M | $13M | $2.41$12.62 |
| JLHL | Julong | $9.48 | $3.13 | 49.29% | 38K | $136M | $2.70$17.49 |
| PBM | Psyence Biomedical | $11.30 | $3.70 | 48.68% | 42.3M | $2.3M | $1.92$74.94 |
| CMPS | Compass Pathways Plc | $9.46 | $2.80 | 42.04% | 39.8M | $640M | $2.25$10.21 |
| INV | Innventure | $6.17 | $1.57 | 34.13% | 395.9K | $368M | $2.36$6.96 |
| VNCE | Vince | $4.49 | $1.09 | 32.06% | 1.2M | $45M | $1.02$4.65 |
| AGPU | Axe Compute | $4.62 | $1.10 | 31.25% | 418.1K | $19M | $1.03$32.10 |
| LVLU | Lulu's Fashion Lounge | $11.31 | $2.31 | 25.67% | 97.7K | $26M | $2.98$32.32 |
| NRXP | NRx Pharmaceuticals | $3.20 | $0.65 | 25.49% | 4.6M | $84M | $1.62$3.84 |
| SST | System1 | $2.68 | $0.53 | 24.65% | 11.3M | $17M | $1.35$15.00 |
| BDRX | Biodexa Pharmaceuticals Plc | $4.33 | $0.85 | 24.43% | 166.9K | $1.6M | $2.86$96.50 |
| DFSC | Defsec Technologies | $2.40 | $0.46 | 23.97% | 2M | $3.9M | $0.22$15.37 |
| BCAB | BioAtla | $5.69 | $1.10 | 23.96% | 143.9K | $7.6M | $3.92$71.50 |
| LFMD | LifeMD | $5.07 | $0.98 | 23.84% | 158.3K | $196M | $2.56$15.84 |
| CAR | Avis Budget Group | $608.80 | $114.94 | 23.27% | 5.7M | $17B | $78.71$612.58 |
| ATXG | Addentax Group | $7.40 | $1.32 | 21.71% | 154.4K | $4.7M | $3.32$27.90 |
| ATAI | AtaiBeckley | $4.90 | $0.87 | 21.59% | 47.1M | $1.5B | $1.29$6.75 |
| MXL | MaxLinear | $31.90 | $5.63 | 21.43% | 344K | $2.3B | $9.07$33.14 |
| BTM | Bitcoin Depot | $6.39 | $1.09 | 20.57% | 43.7K | $60M | $1.91$48.16 |
| MGRT | Mega Fortune | $140.01 | $23.85 | 20.53% | 591 | $1.6B | $1.50$170.00 |
| FCEL | FuelCell Energy | $8.66 | $1.41 | 19.45% | 221.9K | $384M | $3.58$11.99 |
| BLD | TopBuild | $489.86 | $79.55 | 19.39% | 225.2K | $12B | $273.87$559.47 |
| DGXX | Digi Power X | $3.70 | $0.60 | 19.19% | 440K | $218M | $0.85$6.78 |
| WIMI | WiMi Hologram Cloud | $2.36 | $0.38 | 19.19% | 1.1M | $47M | $1.56$5.85 |
| SILA | Sila Realty Trust | $30.39 | $4.86 | 19.04% | 148.2K | $1.4B | $21.94$30.55 |
| PODC | PodcastOne | $2.68 | $0.42 | 18.58% | 1.8K | $62M | $1.30$3.35 |
| ATOM | Atomera | $6.34 | $0.99 | 18.50% | 53.9K | $207M | $1.89$7.73 |
| LEGN | Legend Biotech | $25.08 | $3.91 | 18.47% | 230.4K | $3.9B | $16.24$45.30 |
| POET | Poet Technologies | $8.59 | $1.33 | 18.32% | 45.1M | $659M | $3.58$9.41 |
Related Articles
Featured Article
Trump Just Fast-Tracked Psychedelic Treatments: 3 Under-the-Radar Stocks That Could Be About to Soar
Matthew Benjamin|Apr 20, 2026
Trump is easing approval for psychedelic treatments for mental disorders.
The Psychedelic Revolution in Mental Healthcare
Motley Fool Staff|Apr 17, 2026
Founders of the Integrative Psychiatry Institute, Dr. Will Van Derveer and Keith Kurlander, discuss their new book, Psychedelic Therapy: A Revolutionary Approach to Restoring Mental Health and Reclaiming Your Life.
5 Emerging Tech Stocks I'm Buying on This Sharp Pullback
George Budwell, PhD|Nov 15, 2025
The recent sell-off is an opportunity for long-term investors.
8 AI Stocks I'd Buy Right Now
George Budwell, PhD|Nov 13, 2025
From proven megacaps to speculative small caps, these eight stocks span the AI infrastructure stack at different risk levels.
Why Poet Technologies Stock Soared 16.2% in October
Scott Levine|Nov 9, 2025
This pure-play AI stock caught investors' attention last month for a couple of different reasons.
Is Poet Technologies Stock a Buy?
George Budwell, PhD|Oct 9, 2025
A $75 million capital raise and partnerships with industry giants are fueling optimism, but revenue remains minimal.
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Cory Renauer|Jul 20, 2025
Should You Buy the Dip on Compass Pathways Stock?
Alex Carchidi|Jun 12, 2024
Nothing is going wrong, but one of its peers just hit a serious snag.
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring
Alex Carchidi|May 21, 2024
Psychedelic medicines are rapidly gaining legitimacy on several fronts.
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
Alex Carchidi|Feb 19, 2024
The lofty target is closer to being within reach than it may seem at first.
